1. Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?. (2nd January 2018) Authors: Hierro, C; Alsina, M; Sánchez, M; Serra, V; Rodon, J; Tabernero, J Journal: Annals of oncology Issue: Volume 29:Number 7(2018) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary. (13th November 2017) Authors: Yates, L R; Seoane, J; Le Tourneau, C; Siu, L L; Marais, R; Michiels, S; Soria, J C; Campbell, P; Normanno, N; Scarpa, A; Reis-Filho, J S; Rodon, J; Swanton, C; Andre, F Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 66PAdapting a prescreening program to match molecular alterations in over 5, 000 patients' tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years. (16th September 2018) Authors: Aguilar, S; Vivancos, A; Nuciforo, P; Viaplana, C; Ruiz-Pace, F; Sanchez, E; Rodon, J; Tabernero, J; Garralda, E; Dienstmann, R Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 420PPhase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours. (23rd October 2018) Authors: Bono, P; Massard, C; Peltola, K; Azaro, A; Italiano, A; Kristeleit, R S; Lassen, U N; Arkenau, H-T; Hakulinen, P; Garratt, C; Ikonen, T; Mustonen, M; Rodon, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 284OPrimary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study). (23rd October 2018) Authors: Pernas, S; Villagrasa, P; Vivancos, A; Scaltriti, M; Rodon, J; Burgues, O; Nuciforo, P G; Canes, J; Dueñas, M; Vidal, M; Lluch, A; Perelló, A; Llombart, A; Dorca, J; Montaño, Á; Oliveira, M; Ribas, G; Rapado, I; Prat, A; Ciruelos, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial. (19th September 2018) Authors: Dietrich, P; Wick, W; Hilf, N; Frenzel, K; Gouttefangeas, C; Platten, M; thor Straten, P; Lassen, U; Rodon, J; Bukur, V; Admon, A; van der Burg, S H; von Deimling, A; Kroep, J R; Martinez-Ricarte, F; Okada, H; Ottensmeier, C H; Ponsati, B; Poulsen, H S; Stevanovic, S Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗